Zenith Drugs Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

17.15

17.15

0.40

0.40

0.40

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

52.23

45.07

12.45

9.24

6.17

Loan funds

Secured loans

48.57

23.93

16.79

15.48

12.07

Unsecured loans

-

-

-

-

-

Total

117.95

86.15

29.64

25.12

18.64

Uses of funds

Fixed assets

Gross block

52.15

19.87

16.80

14.23

6.40

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

11.89

8.93

6.35

5.01

-

Net block

40.26

10.94

10.45

9.21

6.40

Capital work-in-progress

3.10

3.91

-

-

2.61

Investments

-

0.03

0.03

-

-

Net current assets

Current assets, loans & advances

118.12

119.30

55.71

37.33

34.72

Less : current liabilities & provisions

43.53

48.02

36.55

21.42

25.08

Total net current assets

74.59

71.28

19.16

15.91

9.64

Miscellaneous expenses not written

-

-

-

-

-

Total

117.95

86.15

29.64

25.12

18.64

Notes:

Book value of unquoted investments

-

0.03

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

12.82

7.72

-

-

-

Number of equity sharesoutstanding (Lacs)

171.49

171.49

4.00

4.00

4.00